🇺🇸 FDA
Patent

US 10787413

Derivatives of curcuminoids and use thereof as an anticancer agent

granted A61KA61K31/12A61K31/222

Quick answer

US patent 10787413 (Derivatives of curcuminoids and use thereof as an anticancer agent) held by China Medical University expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/12, A61K31/222, A61K31/225, A61K31/704